Related references
Note: Only part of the references are listed.Cardioprotection with Postconditioning: Loss of Efficacy in Murine Models of Type-2 and Type-1 Diabetes
Karin Przyklenk et al.
ANTIOXIDANTS & REDOX SIGNALING (2011)
Diabetes mellitus abrogates erythropoietin-induced cardioprotection against ischemic-reperfusion injury by alteration of the RISK/GSK-3 beta signaling
Nehmat Ghaboura et al.
BASIC RESEARCH IN CARDIOLOGY (2011)
Effect of PAR2 in regulating TNF-alpha and NAD(P)H oxidase in coronary arterioles in type 2 diabetic mice
Yoonjung Park et al.
BASIC RESEARCH IN CARDIOLOGY (2011)
Control of cardiovascular differentiation by microRNAs
Kisho Ohtani et al.
BASIC RESEARCH IN CARDIOLOGY (2011)
MicroRNA signatures in total peripheral blood as novel biomarkers for acute myocardial infarction
Benjamin Meder et al.
BASIC RESEARCH IN CARDIOLOGY (2011)
Pioglitazone limits myocardial infarct size, activates Akt, and upregulates cPLA2 and COX-2 in a PPAR-γ-independent manner
Yochai Birnbaum et al.
BASIC RESEARCH IN CARDIOLOGY (2011)
The in-situ pig heart with regional ischemia/reperfusion - Ready for translation
Gerd Heusch et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2011)
Single Dose GLP-1-Tf Ameliorates Myocardial Ischemia/Reperfusion Injury
Muneaki Matsubara et al.
JOURNAL OF SURGICAL RESEARCH (2011)
The myocardial infarct size-limiting effect of sitagliptin is PKA-dependent, whereas the protective effect of pioglitazone is partially dependent on PKA
Yumei Ye et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2010)
Peroxisome proliferator-activated receptor-gamma activation attenuates cardiac fibrosis in type 2 diabetic rats: the effect of rosiglitazone on myocardial expression of receptor for advanced glycation end products and of connective tissue growth factor
Sang-Hyun Ihm et al.
BASIC RESEARCH IN CARDIOLOGY (2010)
Inhibition of mitochondrial permeability transition pore opening: the holy grail of cardioprotection
Gerd Heusch et al.
BASIC RESEARCH IN CARDIOLOGY (2010)
Translating novel strategies for cardioprotection: the Hatter Workshop Recommendations
Derek J. Hausenloy et al.
BASIC RESEARCH IN CARDIOLOGY (2010)
Additive Effect of TAK-491, a New Angiotensin Receptor Blocker, and Pioglitazone, in Reducing Myocardial Infarct Size
Yumei Ye et al.
CARDIOVASCULAR DRUGS AND THERAPY (2010)
Transitory Activation of AMPK at Reperfusion Protects the Ischaemic-Reperfused Rat Myocardium Against Infarction
Marta A. Paiva et al.
CARDIOVASCULAR DRUGS AND THERAPY (2010)
Downregulation of microRNA-29 by antisense inhibitors and a PPAR-γ agonist protects against myocardial ischaemia-reperfusion injury
Yumei Ye et al.
CARDIOVASCULAR RESEARCH (2010)
Postconditioning and protection from reperfusion injury: where do we stand?Position Paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology
Michel Ovize et al.
CARDIOVASCULAR RESEARCH (2010)
Adiponectin An Indispensable Molecule in Rosiglitazone Cardioprotection Following Myocardial Infarction
Ling Tao et al.
CIRCULATION RESEARCH (2010)
Angiotensin II Type 1 Receptor-Mediated Upregulation of Calcineurin Activity Underlies Impairment of Cardioprotective Signaling in Diabetic Hearts
Hiroyuki Hotta et al.
CIRCULATION RESEARCH (2010)
Rosiglitazone-induced myocardial protection against ischaemia-reperfusion injury is mediated via a phosphatidylinositol 3-kinase/Akt-dependent pathway
Xue-Jiao Zhang et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2010)
Global estimates of the prevalence of diabetes for 2010 and 2030
J. E. Shaw et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2010)
Glucagon-Like Peptide (GLP)-1(9-36)Amide-Mediated Cytoprotection Is Blocked by Exendin(9-39) Yet Does Not Require the Known GLP-1 Receptor
Kiwon Ban et al.
ENDOCRINOLOGY (2010)
Diabetes mellitus mitigates cardioprotective effects of remifentanil preconditioning in ischemia-reperfused rat heart in association with anti-apoptotic pathways of survival
Hyun Soo Kim et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2010)
Antidiabetic Drug Voglibose Is Protective Against Ischemia-Reperfusion Injury Through Glucagon-Like Peptide 1 Receptors and the Phosphoinositide 3-Kinase-Akt-Endothelial Nitric Oxide Synthase Pathway in Rabbits
Masamitsu Iwasa et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2010)
Impact of Type of Preadmission Sulfonylureas on Mortality and Cardiovascular Outcomes in Diabetic Patients with Acute Myocardial Infarction
Marianne Zeller et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
被撤回的出版物: Connexin 43 acts as a cytoprotective mediator of signal transduction by stimulating mitochondrial KATP channels in mouse cardiomyocytes (Retracted article. See vol. 122, pg. 4748, 2012)
Dennis Rottlaender et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Antidiabetic drug pioglitazone protects the heart via activation of PPAR-γ receptors, PI3-kinase, Akt, and eNOS pathway in a rabbit model of myocardial infarction
Shinji Yasuda et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2009)
Cross-Talk Between PKA and Akt Protects Endothelial Cells From Apoptosis in the Late Ischemic Preconditioning
Alessandro Bellis et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2009)
Ischemic postconditioning: experimental models and protocol algorithms
Andreas Skyschally et al.
BASIC RESEARCH IN CARDIOLOGY (2009)
Targeting malonyl CoA inhibition of mitochondrial fatty acid uptake as an approach to treat cardiac ischemia/reperfusion
John R. Ussher et al.
BASIC RESEARCH IN CARDIOLOGY (2009)
Lack of cardioprotection from subcutaneously and preischemic administered Liraglutide in a closed chest porcine ischemia reperfusion model
Jens Kristensen et al.
BMC CARDIOVASCULAR DISORDERS (2009)
Rosiglitazone inhibits hypercholesterolaemia-induced myeloperoxidase upregulation-025EFa novel mechanism for the cardioprotective effects of PPAR agonists
Hui-Rong Liu et al.
CARDIOVASCULAR RESEARCH (2009)
Cardiac regulation by phosphoinositide 3-kinases and PTEN
Gavin Y. Oudit et al.
CARDIOVASCULAR RESEARCH (2009)
Loss of cardioprotection with ageing
Kerstin Boengler et al.
CARDIOVASCULAR RESEARCH (2009)
Ischemic Postconditioning in Pigs No Causal Role for RISK Activation
Andreas Skyschally et al.
CIRCULATION RESEARCH (2009)
Activation of AMP-Activated Protein Kinase by Metformin Improves Left Ventricular Function and Survival in Heart Failure
Susheel Gundewar et al.
CIRCULATION RESEARCH (2009)
GLP-1R Agonist Liraglutide Activates Cytoprotective Pathways and Improves Outcomes After Experimental Myocardial Infarction in Mice
Mohammad Hossein Noyan-Ashraf et al.
DIABETES (2009)
The PPAR-γ agonist rosiglitazone facilitates Akt rephosphorylation and inhibits apoptosis in cardiomyocytes during hypoxia/reoxygenation
H. Kilter et al.
DIABETES OBESITY & METABOLISM (2009)
Metformin Prevents Myocardial Reperfusion Injury by Activating the Adenosine Receptor
Marta Paiva et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2009)
Exenatide Reduces Infarct Size and Improves Cardiac Function in a Porcine Model of Ischemia and Reperfusion Injury
Leo Timmers et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials A Position Statement of the American Diabetes Association and a Scientific Statement of the American College of Cardiology Foundation and the American Heart Association
Jay S. Skyler et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
miR-29 miRNAs activate p53 by targeting p85a and CDC42
Seong-Yeon Park et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2009)
The cardioprotective and inotropic components of the postconditioning effects of GLP-1 and GLP-1(9-36)a in an isolated rat heart
Alvilde Ossum et al.
PHARMACOLOGICAL RESEARCH (2009)
The role of eNOS, iNOS, and NF-κB in upregulation and activation of cyclooxygenase-2 and infarct size reduction by atorvastatin
Yumei Ye et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2008)
Pioglitazone protects the myocardium against ischemia-reperfusion injury in eNOS and iNOS knockout mice
Yumei Ye et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2008)
RAGE modulates myocardial injury consequent to LAD infarction via impact on JNK and STAT signaling in a murine model
Alexey Aleshin et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2008)
Simvastatin restores ischemic preconditioning in the presence of hyperglycemia through a nitric oxide-mediated mechanism
Weidong Gu et al.
ANESTHESIOLOGY (2008)
Metformin induces cardioprotection against ischaemia/reperfusion injury in the rat heart 24 hours after administration
Lasse Solskov et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2008)
Maturation-induces endothelial dysfunction via vascular inflammation in diabetic mice
Cuihua Zhang et al.
BASIC RESEARCH IN CARDIOLOGY (2008)
Oral Glyburide, But Not Glimepiride, Blocks the Infarct-Size Limiting Effects of Pioglitazone
Yumei Ye et al.
CARDIOVASCULAR DRUGS AND THERAPY (2008)
Hyperglycemia and acute coronary syndrome - A scientific statement from the American heart association diabetes committee of the council on nutrition, physical activity, and metabolism
Prakash Deedwania et al.
CIRCULATION (2008)
Cardioprotection Nitric Oxide, Protein Kinases, and Mitochondria
Gerd Heusch et al.
CIRCULATION (2008)
Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagon-like peptide 1 receptor-dependent and -independent pathways
Kiwon Ban et al.
CIRCULATION (2008)
Thiazolidinedione drugs block cardiac KATP channels and may increase propensity for ischaemic ventricular fibrillation in pigs
L. Lu et al.
DIABETOLOGIA (2008)
Comparison of pioglitazone vs glimepiride on progression of coronary atherosclerosis in patients with type 2 diabetes -: The PERISCOPE randomized controlled trial
Steven E. Nissen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Phosphorylation of 5-lipoxygenase at Ser(523) by protein kinase a determines whether pioglitazone and atorvastatin induce proinflammatory leukotriene B-4 or anti-inflammatory 15-epi-lipoxin A(4) production
Yumei Ye et al.
JOURNAL OF IMMUNOLOGY (2008)
Pioglitazone, a peroxisome proliferator-activated receptor-γ agonist, attenuates myocardial ischemia-reperfusion injury in mice with metabolic disorders
Tsuyoshi Honda et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2008)
Protective effects of GLP-1 analogues exendin-4 and GLP-1(9-36) amide against ischemia-reperfusion injury in rat heart
David P. Sonne et al.
REGULATORY PEPTIDES (2008)
Ischaemic preconditioning and TNF-α-mediated preconditioning is associated with a differential cPLA2 translocation pattern in early ischaemia
B. Loos et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2008)
Metformin protects the ischemic heart by the Akt-mediated inhibition of mitochondrial permeability transition pore opening
Gurpreet S. Bhamra et al.
BASIC RESEARCH IN CARDIOLOGY (2008)
Acute metformin therapy confers cardioprotection against myocardial infarction via AMPK-eNOS-mediated signaling
John W. Calvert et al.
DIABETES (2008)
The cardioprotection of the late phase of ischemic preconditioning is enhanced by postconditioning via a COX-2-mediated mechanism in conscious rats
Hiroshi Sato et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)
The physiology of glucagon-like peptide 1
Jens Juul Holst
PHYSIOLOGICAL REVIEWS (2007)
Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus - A meta-analysis of randomized trials
A. Michael Lincoff et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
'Warm-up' phenomenon in diabetic patients with stable angina treated with diet or sulfonylureas
Maria Bilinska et al.
CORONARY ARTERY DISEASE (2007)
Myocardial ischaemia-reperfusion injury is attenuated by intact glucagon like peptide-1 (GLP-1) in the in vitro rat heart and may involve the p70s6K pathway
Amal K. Bose et al.
CARDIOVASCULAR DRUGS AND THERAPY (2007)
Activation of peroxisome proliferator-activated receptor-γ (PPAR-γ) by atorvastatin is mediated by 15-deoxy-delta-12,14-PGJ2
Yumei Ye et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2007)
Ischemic postconditioning reduces infarct size by activation of A1 receptors and K+ATP channels in both normal and hypercholesterolemic rabbits
Martin Donato et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2007)
AMP-activated protein kinase in the heart - Role during health and disease
Michael Arad et al.
CIRCULATION RESEARCH (2007)
Aspirin augments 15-epi-lipoxin A4 production by lipopolysaccharide, but blocks the pioglitazone and atorvastatin induction of 15-epi-lipoxin A4 in the rat heart
Yochai Birnbaum et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2007)
Myocardial preconditioning against ischemia-reperfusion injury is abolished in Zucker obese rats with insulin resistance
Prasad V. G. Katakam et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2007)
Cardioprotection mediated by rosiglitazone, a peroxisome proliferatoractivated receptor gamma ligand, in relation to nitric oxide
Adrian T. Gonon et al.
BASIC RESEARCH IN CARDIOLOGY (2007)
Mechanisms of action of glucagon-like peptide 1 in the pancreas
Maire E. Doyle et al.
PHARMACOLOGY & THERAPEUTICS (2007)
Effect of pioglitazone compared with glimepiride on carotid intima-media thickness in type 2 diabetes - A randomized trial
Theodore Mazzone et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes
Daniel J. Drucker et al.
LANCET (2006)
Myocardial protection by pioglitazone, atorvastatin, and their combination: mechanisms and possible interactions
Yumei Ye et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2006)
Augmentation of myocardial production of 15-epi-lipoxin-A4 by pioglitazone and atorvastatin in the rat
Yochai Birnbaum et al.
CIRCULATION (2006)
Cardioprotective effects of rosiglitazone are associated with selective overexpression of type 2 angiotensin receptors and inhibition of p42/44 MAPK
Behzad Molavi et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2006)
Atorvastatin-induced cardioprotection is mediated by increasing inducible nitric oxide synthase and consequent S-nitrosylation of cyclooxygenase-2
S Atar et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2006)
Survival kinases in ischemic preconditioning and postconditioning
Derek J. Hausenloy et al.
CARDIOVASCULAR RESEARCH (2006)
Effects of pharmacological modulation of the ATP-sensitive potassium channels on the development of warm-up angina pectoris
TB Lindhardt et al.
CARDIOLOGY (2006)
Inducible nitric oxide synthase binds, S-nitrosylates, and activates cyclooxygenase-2
SF Kim et al.
SCIENCE (2005)
Pioglitazone mimics preconditioning in the isolated perfused rat heart - A role for the prosurvival kinases PI3K and P42/44MAPK
AM Wynne et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2005)
Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events):: a randomised controlled trial
JA Dormandy et al.
LANCET (2005)
Impairment of diazoxide-induced formation of reactive oxygen species and loss of cardioprotection in Connexin 43 deficient mice
FR Heinzel et al.
CIRCULATION RESEARCH (2005)
Preconditioning the diabetic heart - The importance of Akt phosphorylation
A Tsang et al.
DIABETES (2005)
Postprandial myocardial perfusion in healthy subjects and in type 2 diabetic patients
R Scognamiglio et al.
CIRCULATION (2005)
Sarcolemmal KATP channels:: what do we really know?
TP Flagg et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2005)
The effects of glibenclamide, a KATP channel blocker, on the warm-up phenomenon
BMA Ferreira et al.
ANNALS OF NONINVASIVE ELECTROCARDIOLOGY (2005)
Metformin prevents high-glucose-induced endothelial cell death through a mitochondrial permeability transition-dependent process
D Detaille et al.
DIABETES (2005)
Peroxisome proliferator-activated receptor-γ ligands regulate endothelial membrane superoxide production
JN Hwang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2005)
PPAR-γ activation fails to provide myocardial protection in ischemia and reperfusion in pigs
Y Xu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2005)
Beneficial effects of PPAR-γ ligands in ischemia-reperfusion injury, inflammation and shock
M Abdelrahman et al.
CARDIOVASCULAR RESEARCH (2005)
Glucagon-like peptide 1 can directly protect the heart against ischemia/reperfusion injury
AK Bose et al.
DIABETES (2005)
Rosiglitazone treatment in Zucker diabetic fatty rats is associated with ameliorated cardiac insulin resistance and protection from ischemia/reperfusion-induced myocardial injury
TL Yue et al.
DIABETES (2005)
Increased protein glycation in diabetes mellitus is associated with decreased aspirin-mediated protein acetylation and reduced sensitivity of blood platelets to aspirin
C Watala et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2005)
Prostaglandins mediate the cardioprotective effects of atorvastatin against ischemia-reperfusion injury
Y Birnbaum et al.
CARDIOVASCULAR RESEARCH (2005)
Glucagon like peptide-1 is protective against myocardial ischemia/reperfusion injury when given either as a preconditioning mimetic or at reperfusion in an isolated rat heart model
AK Bose et al.
CARDIOVASCULAR DRUGS AND THERAPY (2005)
Anti-apoptotic effects of rosiglitazone in hypercholesterolemic rabbits subjected to myocardial ischemia and reperfusion
HR Liu et al.
CARDIOVASCULAR RESEARCH (2004)
Effects of glucagon-like peptide-1 in patients with acute myocardial infarction and left ventricular dysfunction after successful reperfusion
LA Nikolaidis et al.
CIRCULATION (2004)
Myocardial protection from either ischaemic preconditioning or nicorandil is not blocked by gliclazide
HL Maddock et al.
CARDIOVASCULAR DRUGS AND THERAPY (2004)
Simvastatin-induced myocardial protection against ischemia-reperfusion injury is mediated by activation of ATP-sensitive K+ channels
S Tavackoli et al.
CORONARY ARTERY DISEASE (2004)
Failure to confer cardioprotection and to increase the expression of heat-shock protein 70 by preconditioning with a κ-opioid receptor agonist during ischaemia and reperfusion in streptozotocin-induced diabetic rats
JS Qi et al.
DIABETOLOGIA (2004)
Ischemic preconditioning attenuates calpain-mediated degradation of structural proteins through a protein kinase A-dependent mechanism
J Inserte et al.
CARDIOVASCULAR RESEARCH (2004)
Multiple, brief coronary occlusions during early reperfusion protect rabbit hearts by targeting cell signaling pathways
XM Yang et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)
Platelet activation in type 2 diabetes mellitus
P Ferroni et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2004)
Protein kinase A as another mediator of ischemic preconditioning independent of protein kinase C
S Sanada et al.
CIRCULATION (2004)
Pleiotropic actions of PPAR gamma activators thiazolidinediones in cardiovascular diseases
H Takano et al.
CURRENT PHARMACEUTICAL DESIGN (2004)
15-deoxy-Δ12,14-prostaglandin J2 and thiazolidinediones transactivate epidermal growth factor and platelet-derived growth factor receptors in vascular smooth muscle cells
T Ichiki et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Admission blood glucose level as risk indicator of death after myocardial infarction in patients with and without diabetes mellitus
I Stranders et al.
ARCHIVES OF INTERNAL MEDICINE (2004)
Pioglitazone, a peroxisome proliferator-activated receptor-γ agonist, attenuates myocardial ischernia/reperfusion injury in a rat model
H Ito et al.
LABORATORY INVESTIGATION (2003)
Troglitazone administration limits infarct size by reduced phosphorylation of canine myocardial connexin43 proteins
TM Lee et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2003)
KATP channels and myocardial preconditioning:: an update
GJ Gross et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2003)
Effect of acute hyperglycemia on the ischemic preconditioning effect of prodromal angina pectoris in patients with a first anterior wall acute myocardial infarction
M Ishihara et al.
AMERICAN JOURNAL OF CARDIOLOGY (2003)
Sulfonylureas and cardiovascular effects: from experimental data to clinical use. Available data in humans and clinical applications
JP Riveline et al.
DIABETES & METABOLISM (2003)
Activation of ATP-dependent potassium channels is a trigger but not a mediator of ischaemic preconditioning in pigs
R Schulz et al.
BRITISH JOURNAL OF PHARMACOLOGY (2003)
B-type natriuretic peptide limits infarct size in rat isolated hearts via KATP channel opening
SP D'Souza et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2003)
Glucagon-like peptide-1 (7-36) amide prevents the accumulation of pyruvate and lactate in the ischemic and non-ischemic porcine myocardium
M Kavianipour et al.
PEPTIDES (2003)
Role of the JAK-STAT pathway in protection against myocardial ischemia/reperfusion injury
R Bolli et al.
TRENDS IN CARDIOVASCULAR MEDICINE (2003)
Impairment of myocardial protection in type 2 diabetic patients
TM Lee et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Peroxisome proliferator-activated receptor gamma ligands increase release of nitric oxide from endothelial cells
DS Calnek et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
Decreased mortality associated with the use of metformin compared with sulfonylurea monotherapy in type 2 diabetes
JA Johnson et al.
DIABETES CARE (2002)
Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans - Role of oxidative stress
K Esposito et al.
CIRCULATION (2002)
Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning?
DJ Hausenloy et al.
CARDIOVASCULAR RESEARCH (2002)
Involvement of endogenous prostaglandins in ischemic preconditioning in pigs
P Gres et al.
CARDIOVASCULAR RESEARCH (2002)
Influence of diabetic state and that of different sulfonylureas on the size of myocardial infarction with and without ischemic preconditioning in rabbits
E Nieszner et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2002)
Ligands of the peroxisome proliferator-activated receptors (PPAR-γ and PPAR-α) reduce myocardial infarct size
NS Wayman et al.
FASEB JOURNAL (2002)
Oral hypoglycemic sulfonylurea glimepiride preserves the myoprotective effects of ischemic preconditioning
H Horimoto et al.
JOURNAL OF SURGICAL RESEARCH (2002)
Isoflurane-induced preconditioning is attenuated by diabetes
K Tanaka et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2002)
Rosiglitazone, a peroxisome proliferator-activated receptor-γ, inhibits the Jun NH2-terminal kinase/activating protein 1 pathway and protects the heart from ischemia/reperfusion injury
N Khandoudi et al.
DIABETES (2002)
Metformin improves cardiac functional recovery after ischemia in rats
RJ Legtenberg et al.
HORMONE AND METABOLIC RESEARCH (2002)
15-deoxy-Δ12,14-prostaglandin J2 and thiazolidinediones activate the MEK/ERK pathway through phosphatidylinositol 3-kinase in vascular smooth muscle cells
K Takeda et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
In vivo myocardial protection from ischemia/reperfusion injury by the peroxisome proliferator-activated receptor-γ agonist rosiglitazone
TL Yue et al.
CIRCULATION (2001)
Acute alcohol-induced protection against infarction in rabbit hearts: Differences from and similarities to ischemic preconditioning
M Krenz et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2001)
Cardioprotective effect afforded by transient exposure to phosphodiesterase III inhibitors - The role of protein kinase A and p38 mitogen-activated protein kinase
S Sanada et al.
CIRCULATION (2001)
Plasminogen activator inhibitor type 1 is increased in the arterial wall of type II diabetic subjects
A Pandolfi et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2001)
Impact of diabetes on long-term survival after acute myocardial infarction - Comparability of risk with prior myocardial infarction
KJ Mukamal et al.
DIABETES CARE (2001)
Glimepiride, a novel sulfonylurea, does not abolish myocardial protection afforded by either ischemic preconditioning or diazoxide
MM Mocanu et al.
CIRCULATION (2001)
Acute hyperglycemia and acute hyperinsulinemia decrease plasma fibrinolytic activity and increase plasminogen activator inhibitor type 1 in the rat
A Pandolfi et al.
ACTA DIABETOLOGICA (2001)
Myocardial KATP channels in preconditioning
B O'Rourke
CIRCULATION RESEARCH (2000)
Sulfonylurea sensitivity of adenosine triphosphate-sensitive potassium channels from β cells and extrapancreatic tissues
FM Gribble et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2000)
Exogenous nitric oxide can trigger a preconditioned state through a free radical mechanism, but endogenous nitric oxide is not a trigger of classical ischemic preconditioning
A Nakano et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2000)
No involvement of endogenous nitric oxide in classical ischemic preconditioning in swine
H Post et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2000)
Heat stress-induced protection of endothelial function against ischaemic injury is abolished by ATP-sensitive potassium channel blockade in the isolated rat heart
M Joyeux et al.
BRITISH JOURNAL OF PHARMACOLOGY (2000)
Myocardial infarction in diabetic vs non-diabetic subjects - Survival and infarct size following therapy with sulfonylureas (glibenclamide)
A Klamann et al.
EUROPEAN HEART JOURNAL (2000)
Preservation of mitochondrial function by diazoxide during sustained ischaemia in the rat heart
T Iwai et al.
BRITISH JOURNAL OF PHARMACOLOGY (2000)
Share Paper
